Lab News & Scientific Highlights

Datum

Hitting cancer from the inside

Medical Science Health Innovation Radiopharmacy

Researchers at the Paul Scherrer Institute PSI are now investigating a new method to channel radioactive substances directly into the nucleus of a cancer cell. Through this approach, the radiation source remains inside the cell and works in a more targeted way, because it gets closer to the cell's genetic information.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.

Medicines made to order with pinpoint precision

Medical Science Health Innovation Radiopharmacy

At PSI, scientists are developing new medicines against cancer. These contain radioactive substances that can be injected into the patients and thus make their way to the tumour. There, in direct contact, their radiation should destroy the cancer cells. Before such a radioactive medicine can be tested on patients in the first clinical trials, however, its safety must be guaranteed to ensure that the patient will not be harmed. Therefore every agent is produced at the PSI under sterile conditions and tested – separately for each patient, and only on the doctor's order.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.

Developing a new drug against thyroid cancer

Medical Science Health Innovation Radiopharmacy

Researchers at the Paul Scherrer Institute PSI have developed a drug to trace and treat a particularly malignant strain of thyroid cancer more effectively. One advantage of the new drug is that it can be used to treat a strain of thyroid cancer where the established treatment is ineffective. The researchers at PSI have developed the new drug to such an extent that an initial study conducted on cancer patients at the University Hospital Basel can now get underway.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.
teaser picture

Probing what sets the heart racing

Media Releases Biology Health Innovation Medical Science

New insights into the workings of important drug receptorsMany medical drugs operate on specific receptors located in the outer walls of our body’s cells. One of these is called the beta-1 adrenergic receptor. Among other things, it is responsible for palpitation, the racing pulse that we feel with stage fright or infatuation. How it transmits signals to the cellular interior can now be revealed in detail. These findings could help scientists better understand many drugs' mode of action.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.

New details of the transmission of stimuli in living organisms unveiled

Media Releases Biology Health Innovation Medical Science

Researchers unveil new details of how cells in a living organism process stimuli. So-called G-proteins, which help conduct external stimuli that reach a cell into its interior, play a central role here. For the first time, the study shows which parts of the G-proteins are vital for their function. Researchers from the Paul Scherrer Institute PSI, ETH Zurich, the pharmaceutical company Roche and the British MRC Laboratory of Molecular Biology report their results in the journals Nature and Nature Structural and Molecular Biology.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.
teaser image

Together, not alone

Research Using Synchrotron Light Large Research Facilities SwissFEL Health Innovation

Decoding biomolecules at SwissFEL and SLSProteins are a coveted but stubborn research object. A method developed for x-ray free-electron lasers and PSI’s future SwissFEL should now help researchers to make good headway in this field. It involves x-raying many small, identical protein samples consecutively at short intervals, thereby avoiding the main problem that protein research has faced thus far: producing samples in a sufficient size.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.
Production route of 44Sc

Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent beta - emitters: In vitro and in vivo study of a 44Sc-DOTA-folate conjugate

Research Division Biology and Chemistry (BIO), Folate Receptor Targeting Group, Head Cristina Müller. In recent years, implementation of 68Ga-radiometalated peptides for PET imaging of cancer has attracted the attention of clinicians. Herein, we propose the use of 44Sc (half-life = 3.97 h, average β+ energy [Eβ+av] = 632 keV) as a valuable alternative to 68Ga (half-life = 68 min, Eβ+av = 830 keV) for imaging and dosimetry before 177Lu-based radionuclide therapy.

Weiterlesen

How botox binds to neurons

Media Releases Biology Research Using Synchrotron Light Health Innovation

Botox is a highly dangerous toxin that causes paralysis. In cosmetic applications it is used to temporarily eliminate wrinkles and in medicine as a treatment for migraine or to correct strabismus. An international research team has now established how the toxin molecule binds to the neuron whose activity is then blocked by the poison. The findings may be useful for the development of improved drugs with a lower risk of overdosage.

Weiterlesen
Dies ist ein Text aus dem PSI-Medien-Archiv. Die Inhalte sind möglicherweise veraltet.